Home/Filings/4/0001225208-20-009616
4//SEC Filing

BIRD JEFFREY W 4

Accession 0001225208-20-009616

CIK 0001269021other

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 7, 3:39 PM ET

Size

28.0 KB

Accession

0001225208-20-009616

Insider Transaction Report

Form 4
Period: 2020-07-02
Transactions
  • Disposition to Issuer

    Common Stock

    2020-07-02$18.00/sh45,402$817,2360 total(indirect: By Partnership)
  • Disposition to Issuer

    Common Stock

    2020-07-02$18.00/sh458,569$8,254,2420 total(indirect: By Trust)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2020-07-026,0000 total
    Exercise: $24.19Exp: 2026-06-01Common Stock (6,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2020-07-0214,1010 total
    Exercise: $19.74Exp: 2023-06-04Common Stock (14,101 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2020-07-026,9910 total
    Exercise: $26.09Exp: 2029-06-12Common Stock (6,991 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2020-07-026,0000 total
    Exercise: $35.06Exp: 2027-06-16Common Stock (6,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2020-07-0210,0000 total
    Exercise: $29.19Exp: 2024-06-27Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2020-07-026,0000 total
    Exercise: $42.81Exp: 2028-06-07Common Stock (6,000 underlying)
  • Disposition to Issuer

    Common Stock

    2020-07-02$18.00/sh20,475$368,5500 total
  • Disposition to Issuer

    Common Stock

    2020-07-02$18.00/sh10,007$180,1260 total(indirect: By Ltd Liability Company (SHM))
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2020-07-0211,3770 total
    Exercise: $17.94Exp: 2030-06-12Common Stock (11,377 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2020-07-0210,0000 total
    Exercise: $44.39Exp: 2025-06-16Common Stock (10,000 underlying)
Footnotes (7)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated as of May 5, 2020, by and among Portola Pharmaceuticals, Inc. (the "Issuer"), Alexion Pharmaceuticals, Inc. ("Alexion") and Odyssey Merger Sub Inc. ("Merger Sub") (the "Merger Agreement"), on July 2, 2020, Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a direct, wholly owned subsidiary of Alexion (the "Merger"). At the effective time of the Merger (the "Effective Time"), these shares were canceled in exchange for $18.00 per share in cash, without interest and subject to any applicable withholding taxes.
  • [F2]The reporting person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in these shares.
  • [F3]Shares held by Sutter Hill Management Company, L.L.C. ("SHM"). Sutter Hill Ventures, a California Limited Partnership ("SHV") has voting and dispositive power over the shares held by SHM, and the reporting person is a trustee of a trust which is a member of SHM. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
  • [F4]Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership of these shares except as to the reporting person's pecuniary interest therein.
  • [F5]Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.
  • [F6]In connection with the Merger, these options were canceled without payment.
  • [F7]At the Effective Time, this unvested and outstanding option was accelerated, canceled and converted into the right to receive a cash amount equal to the product of (i) the number of shares that are subject to such options and (ii) $18.00 less the applicable exercise price per share of such options, subject to any applicable withholding or other taxes required by applicable law.

Documents

1 file

Issuer

PORTOLA PHARMACEUTICALS INC

CIK 0001269021

Entity typeother

Related Parties

1
  • filerCIK 0001250409

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 7, 3:39 PM ET
Size
28.0 KB